Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Hopkins, F. J. F. Herth, G. Snell, K. Baker, C. Witt, M. H. Gotfried, A. Valipour, M. Wagner, F. Stanzel, J. Egan, S. Kesten, A. Ernst (Chermside, Melbourne, Australia; Heidelberg, Berlin, Nuremberg, Hemer, Germany; Iowa City, Phoenix, Tustin, Boston, United States Of America; Vienna, Austria; Dublin, Ireland). Associations of efficacy outcomes following bronchoscopic thermal vapor ablation (BTVA) for the treatment of heterogeneous emphysema. Eur Respir J 2011; 38: Suppl. 55, 3531

Member's Comments

No comment yet.

Related content which might interest you: Associations among one-year efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) for heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 The influence of baseline exercise tolerance on long-term efficacy outcomes following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 The influence of emphysema heterogeneity on the magnitude of benefit following endoscopic thermal vapor ablation (InterVaporÔ) in patients with heterogeneous emphysema Source: Annual Congress 2012 - Endoscopic lung volume reduction: the growing evidence Year: 2012 Sustained efficacy from 3 to 6 months following bronchoscopic thermal vapor ablation (BTVA) in the treatment of heterogeneous emphysema Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011 Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema Source: Eur Respir J 2012; 39: 1326-1333 Year: 2012 Germany pilot safety and feasibility study of bronchoscopic thermal vapor ablation (BTVA) for lung volume reduction in patients with heterogeneous emphysema with upper lobe predominance Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Impact of radiological changes on treatment outcome following endoscopic lung volume reduction with coils (LVRC) in patients with advanced emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011 Removal of diseased emphysematous tissue with bronchoscopic thermal vapor ablation (BTVA) Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Endoscopic lung volume reduction (ELVR) treatment for patients with severe heterogeneous emphysema and bilateral incomplete fissures. Effectiveness and complications of coils´ implantation at 90 days follow up Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 A safety and feasibility study of the chartis system in subjects with heterogeneous emphysema prior to endobronchial lung volume reduction (ELVR) Source: Annual Congress 2009 - Treatment beyond inhalers Year: 2009 Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Efficacy and safety of bronchoscopic lung volume reduction (BLVR) modalities functioning independent of collateral ventilation in advanced emphysema: Systematic review and meta-analysis Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Lung volume reduction coil (LVRC) treatment is safe and effective in heterogeneous and homogeneous emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Bronchoscopic lung volume reduction with coils (BLVR-Coils) for treatment of patients with severe heterogeneous emphysema and bilaterally incomplete fissures. Its effectiveness in everyday endoscopic practice Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Feasibility and safety of endoscopic microwave ablation for malignant central airway obstruction; a case series. Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 High resolution computed tomography (HRCT) measurements of lobar volume reduction associated with bronchoscopic thermal vapor ablation (BTVA) in patients with heterogeneous emphysema Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011 Percutaneous computed tomography-guided radiofrequency thermal ablation: Efficacy and safety in lung cancer Source: Annual Congress 2011 - The basic and the future: pure diagnostic or dedicated wavelengths play Year: 2011